Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor
vorinostat in patients with advanced solid tumors.
The team studied
Vorinostat in 16 patients living with HIV whose viral load was controlled through standard antiviral therapy.
This spring, a clinical trial will start at the Alberta Children's Hospital exploring the clinical efficacy of
vorinostat in children who have failed to respond to current anti-seizure medications.
A phase I clinical trial conducted by investigators at the University of Texas San Antonio, showed that the combination of HCQ and the chemotherapy drug
vorinostat in 27 patients with advanced solid tumors, including renal cell carcinoma and colon cancer, was clinically safe and inhibited autophagy.
Not exact matches
One of the more intriguing findings
in the study was that increasing histone crotonylation works synergistically with other known anti-HIV latency molecules, such as the protein kinase C agonist PEP005 and the HDAC inhibitor
vorinostat.
We are currently investigating
vorinostat plus standard therapies to prevent GVHD
in transplants with an unrelated donor.»
«We tested a drug currently used for cancer treatment (
vorinostat (Zolinza)-RRB- and found that it reduced average daily seizures
in zebrafish and mouse models by 60 per cent,» says Kurrasch.
By screening commercially available drugs currently being used for other diseases, researchers found
vorinostat to be an effective anti-seizure drug
in zebrafish and mouse models.
Five years ago, he enrolled
in a study at the UNC School of Medicine, which was part of Dr. David Margolis» «kick and kill» strategy for eradicating HIV by flushing it out of hiding with a drug called
Vorinostat and killing it with either a vaccine
Vorinostat interferes with the signaling transduction pathway of T - cell receptor and synergizes with phosphoinositide - 3 kinase inhibitors
in cutaneous T - cell lymphoma
«We showed that a single dose of
Vorinostat could expose the hidden virus several years ago, but it has taken two studies over the last five years to define the proper interval dosing strategy to use
Vorinostat safely and effectively,» said Nancie Archin Ph.D., lead author of this study and an assistant professor
in the Division of Infectious Diseases at UNC.